key: cord-0975760-n6no43d1 authors: Victor, Joshua; Deutsch, Jamie; Whitaker, Annalis; Lamkin, Erica N.; March, Anthony; Zhou, Pei; Botten, Jason W.; Chatterjee, Nimrat title: SARS-CoV-2 triggers DNA damage response in Vero E6 cells date: 2021-09-15 journal: Biochem Biophys Res Commun DOI: 10.1016/j.bbrc.2021.09.024 sha: ed4e2156bf496d98bc7251a56a94ffab15179737 doc_id: 975760 cord_uid: n6no43d1 The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus responsible for the current COVID-19 pandemic and has now infected more than 200 million people with more than 4 million deaths globally. Recent data suggest that symptoms and general malaise may continue long after the infection has ended in recovered patients, suggesting that SARS-CoV-2 infection has profound consequences in the host cells. Here we report that SARS-CoV-2 infection can trigger a DNA damage response (DDR) in African green monkey kidney cells (Vero E6). We observed a transcriptional upregulation of the Ataxia telangiectasia and Rad3 related protein (ATR) in infected cells. In addition, we observed enhanced phosphorylation of CHK1, a downstream effector of the ATR DNA damage response, as well as H2AX. Strikingly, SARS-CoV-2 infection lowered the expression of TRF2 shelterin-protein complex, and reduced telomere lengths in infected Vero E6 cells. Thus, our observations suggest SARS-CoV-2 may have pathological consequences to host cells beyond evoking an immunopathogenic immune response. pandemic. SARS-CoV-2 is a zoonotic positive-sense RNA virus from the Coronaviridae family of viruses. Since the inception of the pandemic more than 4 million deaths have occurred and some recovered patients have continued to report debilitating, and sometimes new symptoms long after the infection has ended. This condition with lingering symptoms is often referred to as "Long COVID". Although mechanisms are unclear, hypotheses include viral-induced tissue and organ injury, in which SARS-CoV-2 infection alters host cell physiology, and cellular functions might be permanently altered. Hence there is an urgent need to understand the pathobiology of SARS-CoV-2, that might shed light on the causes of long-term symptoms [1] [2] [3] [4] [5] . RNA viruses are the etiologic agents of many prevalent and lethal human diseases 6 . It is well documented that despite the completion of their life cycle within the host cell cytoplasm, RNA viruses can induce significant DNA damage and activate the DNA damage response (DDR) pathway. Both events enable viral replication and modulation of host cell functions. Notably, the positive-sense RNA viruses from the family Coronaviridae to which the SARS-CoV-2 belongs, and the negative-strand Influenza A virus from the Orthomyxoviridae family induces the DDR pathway in host cells [7] [8] [9] . More J o u r n a l P r e -p r o o f recently, global phosphorylation mapping 10 and ATR DDR inhibitor studies 11 indicate that SARS-CoV-2 may also engage the DDR pathway to propagate in host cells. A classical DNA damage response is mediated by one of the signaling pathways-ATM, ATR, and DNA-PK kinases 6 . Double strand breaks usually engage the ATM and the DNA-PK pathways, while single-stranded DNA activates the ATR kinase pathway 12 . These pathways activate specific downstream effectors such as CHK1 by ATR and CHK2 by ATM to trigger a cellular response that allows cells to arrest cell cycle progression to repair damaged DNA. The DDR pathway is a critical component of an intracellular defense mechanism that is activated upon detection of lesions on the DNA to facilitate DNA repair by any of the following: base excision repair (BER), nucleotide excision repair (NER), mismatch repair (MMR), non-homologous end-joining (NHEJ) or homologous recombination (HR) to fix the damaged DNA 13 . In the event that DNA repair fails, either programmed cell death is induced, or an alternative pathway of DNA damage tolerance or translesion synthesis (TLS) is triggered 14 to allow cell survival despite the presence of DNA damage. Additionally, it is known that ATR and ATMdependent DNA damage responses associate with telomere dysfunction 15, 16 . Telomeres are specialized DNA-protein structures that play a key role in maintaining genome stability by protecting the ends of chromosomes 17 . The shelterin protein complex, comprised of six proteins-TRF1, TRF2, POT1, TPP1, TIN2 and Rap1specifically associate with telomeric sequences to prevent the chromosomal ends from being recognized as double strand breaks 18 . Depletion or loss of components of the shelterin complex results in telomere shortening 19 . Literature survey suggests that The lysate was mixed thoroughly, followed by addition of one volume of 70% ethanol (Fisher Scientific) and mixed again by pipetting. The lysate was then transferred to the RNeasy spin column provided in the RNeasy kit (Qiagen). The manufacturers protocol was then followed for the rest of the isolation process. cells at an MOI of 0.01 and tested expression of DDR genes after 48 hours (Fig. 1A) . At this MOI and exposure time frame, Vero E6 cells produce maximal infectious virus outputs 21 and remain infected with SARS-CoV-2, as is indicated the relative N2 transcript levels in the SARS-CoV-2 infected cells (Fig. 1B) Fig. 1C and 2A) . Within this context, we did not see an enhanced phosphorylation of the ATR protein or the total ATR protein levels in infected cells ( Fig. 2A and 2B) , suggesting that the overall increase in ATR levels corresponding to the increased mRNA levels may have occurred prior to our test time of 48 hours. In fact, we observe an overall reduction in both the total ATR and CHK1 protein levels at 48 hours (Fig. 2B) To quantify possible effects of an activated ATR DNA damage response in infected cells, we measured telomere lengths both in mock and SARS-CoV-2 infected cells. We used the commercially available qPCR-based Relative Telomere Length Quantification kit and compared the relative amplification of the telomere end to the internal control. Strikingly, we observed that SARS-CoV-2 infection shortens the relative length of telomeres compared to mock controls within 48 hours (Fig. 3A) . In addition, we examined the relative expression of one of the key telomere proteins, TRF2, and found its expression to be significantly suppressed in SARS-CoV-2 infected Vero E6 cells ( Fig. 3B and C) . Whether other cell types, such as rodent or human cells would exhibit a similar telomere phenotype post-SARS-CoV-2 infection needs to be ascertained. TRF2 is one of the most important shelterin complex proteins that ensure telomere end J o u r n a l P r e -p r o o f SARS-CoV-2 has made a lasting impact across the globe infecting millions of people, and spurred concern due to long-term health consequences. With the advent of the continuously evolving strains, studying the pathobiological consequences of this infection in recovered patients is vital. This study suggests that in Vero E6 cells, SARS-CoV-2 infection triggers an ATR DNA damage response and affects telomere function. Both ATR activation and telomere instability are associated with genome instability. Further studies are required to expand these findings and ascertain the clinical implications of these results. J o u r n a l P r e -p r o o f The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 WHO COVID-19 Dashboard Coronavirus biology and replication: implications for SARS-CoV-2 The trinity of COVID-19: immunity, inflammation and intervention Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication Activation of the DNA Damage Response by RNA Viruses Coronavirus infection induces DNA replication stress partly through interaction of its nonstructural protein 13 with the p125 subunit of DNA polymerase delta Influenza infection induces host DNA damage and dynamic DNA damage responses during tissue regeneration Detection of influenza virus induced DNA damage by comet assay The Global Phosphorylation Landscape of SARS-CoV-2 Infection initiators of the cellular genotoxic stress responses Endogenous DNA Damage as a Source of Genomic Instability in Cancer Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy? ATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma Telomere-related genome instability in cancer Telomeric armor: the layers of end protection The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress Predicting Infectivity: Comparing Four PCR-based Assays to Detect Culturable SARS-CoV-2 in Clinical Samples Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31 ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo Avian reovirus S1133-induced DNA damage signaling and subsequent apoptosis in cultured cells and in chickens Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitis virus in the absence of p53 Control of human telomere length by TRF1 and TRF2 TRF2-mediated telomere protection is dispensable in pluripotent stem cells Telomere shortening in human diseases J o u r n a l P r e -p r o o f